Catalyst Wire Dossier Catalyst Wire Dossier

Rapiscan

regadenoson · GE Healthcare AS
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rapiscan, covering 2025-12-17 to 2025-12-17. Get the full timeline:

Most recent: EMA Authorised: Rapiscan (regadenoson) — GE Healthcare AS

See pricing